Ideas about what constitutes "normal" labor progression and labor "arrest" may require revision, according to a new study.
Ideas about what constitutes "normal" labor progression and labor "arrest" may require revision, according to the findings of a recent multicenter retrospective study. Researchers from the National Institutes of Health found that among a large contemporary population of women in the United States, progress from 4 cm to 6 cm of dilation was far slower than what is perceived to be normal.
The Consortium on Safe Labor study included more than 62,000 women with a singleton term gestation, spontaneous onset of labor, vertex presentation, vaginal delivery, and a normal perinatal outcome. Using electronic medical records from 19 US hospitals, the authors found that women frequently take more than 6 hours to progress from 4 cm to 5 cm and more than 3 hours to progress from 5 cm to 6 cm, regardless of parity. Although labor accelerates much faster after 6 cm in all women, it does so more for multiparous women; thus, although no appreciable change in dilation for 4 hours may be normal in early labor, it is probably not normal after 6 cm. The 95th percentiles of the second stage of labor in nulliparous women with and without epidural analgesia were 3.6 hours and 2.8 hours, respectively.
Researchers also found that even in women with rapid cervical dilation in the late first stage, the active phase often did not start until dilation had attained 6 cm or more.
Zhang J, Landy HJ, Branch DW, et al. Contemporary patterns of spontaneous labor with normal neonatal outcomes. Obstet Gynecol. 2010;116(6):1281–1287.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More